The Hidden Cost of Conception: Male Infertility Treatment Costs Nearly As Much As Endometriosis in India, Study Reveals

NEW DELHI — A groundbreaking multicentric study published in the Indian Journal of Medical Research (IJMR) has shattered long-held assumptions about reproductive healthcare costs in India. The research reveals that treating male infertility is nearly as expensive as treating endometriosis—a chronic, debilitating gynecological condition widely notorious for its high cost of care. By exposing an annual cost difference of just ₹377 between the two conditions, the study highlights a massive, under-recognized public health and financial crisis quietly affecting millions of families across the country.

Key Findings: Financial Shockwaves for Families

The study, which tracked expenditure across both public and private tertiary healthcare facilities (specialized hospitals providing advanced care), analyzed the out-of-pocket expenses of 500 couples seeking treatment for the five most common causes of infertility.

To the surprise of many researchers, the financial burden of male reproductive health issues closely mirrored that of complex female reproductive conditions.

Annual Infertility Treatment Costs in India

The data shows that male infertility treatment sits well above the general average for fertility care. Furthermore, male factors accounted for nearly one-fifth of all definitive infertility diagnoses among the participating couples, underscoring that men are equal stakeholders in both the medical and financial aspects of conception.

Shifting the Narrative on an Overlooked Crisis

Infertility is defined by the World Health Organization (WHO) as the inability to achieve a pregnancy after 12 months or more of regular, unprotected sexual intercourse. The WHO estimates that approximately 17.5% of the global adult population—about one in six people—will experience infertility in their lifetime, making it a universal health issue that spans geographic and economic boundaries.

In India, the crisis carries a particularly heavy social and economic toll. Top fertility experts estimate that out of the roughly 27.5 million individuals currently grappling with infertility nationwide, male factors contribute to 40% to 50% of the cases.

Historically, Indian societal narratives have disproportionately placed the emotional and medical burden of childlessness on women. These new economic data challenge those gendered biases by proving that the medical reality—and the accompanying bill—is shared across partners.

Why Is Male Infertility Treatment So Expensive?

The high cost of male infertility care stems from a multi-layered diagnostic and therapeutic pipeline. Pinpointing the root cause of male reproductive issues often requires a battery of sophisticated tests, while solutions frequently involve advanced technological interventions.

[Initial Semen Analysis & Consultations]
                  │
                  ▼
[Specialized Testing: Hormonal, Genetic & Ultrasounds]
                  │
                  ▼
┌─────────────────┴─────────────────┐
▼                                   ▼
[Medical/Hormonal Therapies]        [Surgical Interventions / ART]
(₹1,000 - ₹5,000/month)             (₹15,000 - ₹4,000,000+)

The medical journey typically involves:

• Advanced Diagnostics: Initial semen analysis, endocrine (hormone) profiling, scrotal ultrasounds, and specialized genetic testing to evaluate DNA fragmentation.

• Therapies and Interventions: Depending on the diagnosis, care can range from ongoing hormone medications to corrective surgeries (such as varicocelectomy to repair enlarged veins in the scrotum).

• Assisted Reproductive Technology (ART): In severe cases, couples must utilize advanced procedures like Intrauterine Insemination (IUI) or Intracytoplasmic Sperm Injection (ICSI)—a specialized form of In Vitro Fertilization (IVF) where a single sperm is injected directly into an egg.

According to baseline industry data, costs escalate rapidly depending on the severity of the condition:

• Medications: ₹1,000 to ₹5,000 per month.

• Basic Surgical Interventions: ₹15,000 to over ₹1,00,000.

• Advanced ART Procedures (IVF/ICSI): ₹2,00,000 to ₹4,00,000 or more per cycle.

The IJMR study emphasizes that direct medical costs—such as consultations, lab fees, and prescription drugs—comprise the largest chunk of family spending. However, indirect expenses also drain household finances. On average, couples traveled 57 kilometers per visit to access care, with some traveling over 1,000 kilometers. These journeys result in substantial accumulated costs for transport, lodging, and lost daily wages.

The Public vs. Private Divide

The research exposes a stark financial divide between India’s public and private healthcare sectors. The median annual out-of-pocket expenditure was significantly higher in private facilities:

₹14,217 (Private Facilities) vs. ₹8,355 (Public Facilities)

Direct medical expenses in private clinics were nearly four times more expensive than in government hospitals. However, public sector patients paid a different kind of price: because specialized fertility care is overwhelmingly concentrated in urban, tertiary-level government centers, rural and semi-urban patients using public care faced significantly higher travel times and steeper indirect losses in income.

60% of Couples Face “Catastrophic” Financial Distress

Perhaps the most alarming revelation from the IJMR study is that 59.4% of couples experienced catastrophic health expenditure while seeking infertility care. Economists define health spending as “catastrophic” when it exceeds 40% of a household’s annual non-food expenditure.

The families found to be at the absolute highest risk for financial ruin included:

1. Lower-income households.

2. Couples undergoing repeated cycles of IUI or IVF treatment.

3. Patients managing secondary chronic medical conditions alongside infertility.

Compounding this financial vulnerability is a near-total absence of structural support. A mere 1% of the study’s participants reported having any form of insurance coverage for infertility treatments. To compensate, the vast majority of couples reported depleting their lifetime savings, selling family assets, or turning to high-interest informal loans to keep their medical hopes alive.

Independent Experts Call for Urgent Policy Overhaul

“These findings challenge deep-seated gender assumptions surrounding infertility and expose a major financial blind spot that policymakers have overlooked for decades,” noted an independent reproductive health specialist who reviewed the data.

“By proving that treating male infertility can be just as financially devastating as treating complex gynecological conditions like endometriosis, this study demonstrates that reproductive health is not just a ‘woman’s issue.’ It is an economic family crisis that demands structural reform.”

Historically, infertility treatments have been excluded from major public health programs and insurance mandates in India, viewed largely as luxury or elective procedures rather than essential medical care. Public health advocates argue that this study provides the objective data needed to push for the integration of fertility services into national health insurance frameworks, such as Ayushman Bharat, or to mandate standard private insurance inclusion.

Balancing the Findings: Study Limitations

While the study offers vital insights, independent analysts point out certain limitations. Because the data was collected strictly from tertiary-level healthcare facilities, the cost structures may not accurately reflect expenses at smaller, primary or secondary community clinics.

Additionally, the study focused on immediate, self-reported out-of-pocket expenditures over a specific period. It did not capture the long-term macro-economic impacts on these families, such as generational debt cycles, career stagnation, or the long-term mental health costs associated with financial and reproductive stress. Further research across a broader, more diverse geographic landscape will be required to shape nationwide policy changes.

A New Path Forward for Public Health

The timing of this study coincides with a growing global movement to recognize reproductive struggles as a core component of universal health rights. The intense emotional, psychological, and social consequences of infertility—including marital strain and profound social stigma in India—are heavily aggravated by the threat of financial ruin.

For couples navigating the difficult road toward building a family, these findings offer validation. By demonstrating that the financial toll of male infertility is real, substantial, and measurable, the medical community hopes to reduce the unwarranted stigma surrounding male reproductive health. Ultimately, the study underscores a vital reality for policymakers: reproductive challenges affect both partners equally, and the financial toll compromises the well-being of the entire family.

References

• NDTV Health. “Male Infertility Costs Nearly As Much As Endometriosis Treatment In India: Study.” Published June 7, 2026.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.